Related Experiment Video
Updated: Aug 21, 2026

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
No global loss of neocortical neurons in Parkinson's disease: a quantitative stereological study
Kamilla M Pedersen1, Lisbeth Marner, Henning Pakkenberg
1Research Laboratory for Stereology and Neuroscience, H.S. Bispebjerg University Hospital, Copenhagen, Denmark.
Abstract:
The global total number of neocortical neurons was estimated in 10 patients with Parkinson's disease (PD; mean age, 74.8 years; range, 68-83) and compared to 12 comparison subjects (mean age, 75.8 years; range, 70 - 84). The total mean neocortical neuron number in the patients with PD was 18.6 x 10(9) with a coefficient of variation (CV = SD/mean) of 0.18, which was not statistically significantly different from that of the controls (18.8 x 10(9); CV = 0.16; P = 0.90). In contrast to some studies reporting neocortical atrophy this was not confirmed in our study, where the mean volume of neocortex was the same in the two groups (P = 0.59). No difference was found in the volume of white matter, central gray structures, archicortex, or the ventricular system between the two groups. Most patients with PD develop cognitive disturbances with time, and this study cannot exclude that local neuron loss in specific subpopulations of neocortical neurons or cell loss in small but essential neocortical subregions may be part of the structural defects of PD.
More Related Videos
08:19Stereological Estimation of Dopaminergic Neuron Number in the Mouse Substantia Nigra Using the Optical Fractionator and Standard Microscopy Equipment
Published on: September 1, 2017
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...